| Blebs promote cell survival by assembling oncogenic signalling hubs AD Weems, ES Welf, MK Driscoll, FY Zhou, H Mazloom-Farsibaf, ... Nature 615 (7952), 517-525, 2023 | 43 | 2023 |
| Enhanced dendritic actin network formation in extended lamellipodia drives proliferation in growth-challenged Rac1P29S melanoma cells AS Mohan, KM Dean, T Isogai, SY Kasitinon, VS Murali, P Roudot, ... Developmental cell 49 (3), 444-460. e9, 2019 | 40 | 2019 |
| Real-time multi-angle projection imaging of biological dynamics BJ Chang, JD Manton, E Sapoznik, T Pohlkamp, TS Terrones, ES Welf, ... Nature methods 18 (7), 829-834, 2021 | 30 | 2021 |
| An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments VS Murali, BJ Chang, R Fiolka, G Danuser, MC Cobanoglu, ES Welf BMC Cancer 19 (502), 2019 | 25 | 2019 |
| Rapid detection of polyethylene glycol sonolysis upon functionalization of carbon nanomaterials VS Murali, R Wang, CA Mikoryak, P Pantano, R Draper Experimental biology and medicine 240 (9), 1147-1151, 2015 | 23 | 2015 |
| The impact of subcellular location on the near infrared-mediated thermal ablation of cells by targeted carbon nanotubes VS Murali, R Wang, CA Mikoryak, P Pantano, RK Draper Nanotechnology 27 (42), 425102, 2016 | 11 | 2016 |
| Hyperactive Rac1 drives MAPK-independent proliferation in melanoma by assembly of a mechanosensitive dendritic actin network AS Mohan, KM Dean, SY Kasitinon, T Isogai, V Siruvallur Murali, SJ Han, ... BioRxiv, 326710, 2018 | 6 | 2018 |
| Detecting sonolysis of polyethylene glycol upon functionalizing carbon nanotubes R Wang, VS Murali, R Draper Cancer Nanotechnology: Methods and Protocols, 147-164, 2017 | 6 | 2017 |
| Proteolysis-free cell migration through crowded environments via mechanical worrying MK Driscoll, ES Welf, A Weems, E Sapoznik, F Zhou, VS Murali, ... | 5 | 2020 |
| Worrying drives cell migration in mechanically unrestrained environments ES Welf, MK Driscoll, E Sapoznik, VS Murali, A Weems, M Roh-Johnson, ... bioRxiv 372912, 2020 | 5* | 2020 |
| Effect of carbon nanotube amount and subcellular location on the near infrared (NIR) photothermal ablation of cells VS Murali, C Mikoryak, R Wang, RK Draper Cancer Research 74 (19_Supplement), 5374-5374, 2014 | 5 | 2014 |
| Evaluating Melanoma Viability and Proliferation in 3D Microenvironments V Siruvallur Murali., MC Cobanoglu., E Welf S. Methods in Molecular Biology 2265, 155-171, 2021 | 3 | 2021 |
| Cancer drug discovery as a low rank tensor completion problem VS Murali, D Ağaç Çobanoğlu, M Hsieh, M Zinn, VS Malladi, J Gesell, ... bioRxiv, 2021.03. 08.434311, 2021 | 1 | 2021 |
| RhoA activation promotes glucose uptake to elevate proliferation in MAPK inhibitor resistant melanoma cells VS Murali, D Rajendran, T Isogai, RJ DeBerardinis, G Danuser bioRxiv, 2024 | | 2024 |
| RhoA activation promotes glucose uptake to elevate proliferation in MAPK inhibitor resistant melanoma cells. V Siruvallur Murali, D Rajendran, T Isogai, RJ DeBerardinis, G Danuser bioRxiv, 2024.01. 09.574940, 2024 | | 2024 |
| Engineering a 3D melanoma microenvironment and identifying novel therapeutic targets. VS Murali, J Cillay, E Welf, G Danuser, MC Cobanoglu CANCER RESEARCH 80 (19), 43-44, 2020 | | 2020 |
| Abstract A27: Engineering a 3D melanoma microenvironment and identifying novel therapeutic targets VS Murali, J Cillay, E Welf, G Danuser, MC Cobanoglu Cancer Research 80 (19_Supplement), A27-A27, 2020 | | 2020 |
| Robust high content assessment of heterogeneous drug effects in 3D microenvironments VS Murali, BJ Chang, R Fiolka, G Danuser, MC Cobanoglu, ES Welf bioRxiv, 312504, 2018 | | 2018 |
| 1264 Rac1P29S coordinates the actin cytoskeleton to mediate a mechanosensitive proliferative advantage in melanoma AS Mohan, KM Dean, V Murali, S Yuan, T Isogai, SJ Han, ES Welf, ... Journal of Investigative Dermatology 138 (5), S214, 2018 | | 2018 |
| Development of an Ex Vivo 3D Functional Assay for Novel Drug Discoveries VS Murali, G Danuser, MC Cobanoglu The Journal of Immunology 198 (1_Supplement), 205.8-205.8, 2017 | | 2017 |
Erik S WelfRegeneron PharmaceuticalsZweryfikowany adres z regeneron.com
